Relapsed Non Hodgkin Lymphoma Not Yet Recruiting Phase 2 Trials for Azacitidine (DB00928)

IndicationStatusPhase
DBCOND0062858 (Relapsed Non Hodgkin Lymphoma)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03719989Azacitidine and Rituximab-GDP Immunochemotherapy in Patients With Relapsed/Refractory Diffuse Large B-Cell LymphomaTreatment